Systematic evaluation of the T30 neurostimulator (acoustic CR): double-blind randomized placebo-controlled trial

Record details

Authors: Hall DA, Pierzycki RH, Thomas H, Greenberg D, Sereda M, Hoare DJ.
Journal / source: Brain Sciences (2022)
Design: Double-blind randomized placebo-controlled trial with open-label extension (NCT01541969)
Sample: 100
Primary endpoint: Tinnitus Handicap Questionnaire at 12 weeks
Randomized: Yes · Sham/placebo-controlled: Yes · Independent of the manufacturer: Yes

What this research found

No benefit over placebo on the primary outcome (p=0.85).

The definitive independent test of acoustic coordinated reset. An earlier industry-co-authored commentary (Front Psychol 2017) had called the RESET2 program 'non-conclusive'.

Limitations and conflicts of interest

—

Funding / conflicts: Independent (NIHR Nottingham).

Primary sources

Used as evidence for

Acoustic coordinated reset (Desyncra)

This is an original summary from the Tinnitus Evidence verified database, checked against the primary source — not a reproduction of the publisher's abstract.